Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Cilostazol in Diabetes Mellitus, Type 2: NCT07719894 Clinical Landscape Report 2026
15 October 2026
NCT07719894 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Orforglipron in Obesity: NCT07729332 Clinical Landscape Report 2026
15 October 2026
NCT07729332 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Deoxycholic Acid in Localized obesity: NCT07743788 Clinical Landscape Report 2026
15 October 2026
NCT07743788 clinical landscape for Localized obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Morphine Sulfate in Colonic Cancer: CTRI/2026/08/115239 Clinical Landscape Report 2026
15 October 2026
CTRI/2026/08/115239 clinical landscape for Colonic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Deoxycholic Acid in Obesity, Abdominal: NCT07749742 Clinical Landscape Report 2026
15 October 2026
NCT07749742 clinical landscape for Obesity, Abdominal: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HS-10535 in Obesity: NCT07748351 Clinical Landscape Report 2026
15 October 2026
NCT07748351 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Obesity: NCT07732426 Clinical Landscape Report 2026
15 October 2026
NCT07732426 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GLP-1 agonist (Nxera Pharma) in Metabolic Syndrome: NCT07740291 Clinical Landscape Report 2026
15 October 2026
NCT07740291 clinical landscape for Metabolic Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BI-3034701 in Obesity: NCT07754474 Clinical Landscape Report 2026
15 October 2026
NCT07754474 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Probiotics (Jiangzhong) in Colonic Cancer: CTRI/2026/07/114785 Clinical Landscape Report 2026
15 October 2026
CTRI/2026/07/114785 clinical landscape for Colonic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sevoflurane in Complications of bariatric procedures: NCT07748247 Clinical Landscape Report 2026
15 October 2026
NCT07748247 clinical landscape for Complications of bariatric procedures: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
GUB-014295 in Obesity: NCT07752979 Clinical Landscape Report 2026
15 October 2026
NCT07752979 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.